Medications
Ozempic, Wegovy, Compounded Semaglutide
Monthly Cost
$49/mo + $299 meds
Speed to Start
Fast
Est. 2013
About Lemonaid Health
Lemonaid Health takes a deliberately simple approach to GLP-1 access: skip the insurance hassle, pay cash, get your medication fast. Founded in 2013 and now part of 23andMe, the platform leverages its parent company’s health-data expertise while maintaining a lean, efficient prescription service.
The medication menu includes both brand-name options (Ozempic, Wegovy) and compounded semaglutide for patients seeking a lower-cost alternative. Monthly pricing starts at $49/month plus $299 for medication, positioning Lemonaid in the mid-range for total cost. The self-pay model eliminates insurance paperwork — appealing for patients who want speed over savings from coverage.
Lemonaid’s association with 23andMe adds a unique dimension. While the GLP-1 program itself doesn’t directly integrate genetic data, the parent company’s emphasis on data-driven health decisions informs the platform’s approach to clinical care. Fast shipping is a noted advantage — patients receive medications quickly once prescribed.
With a 4.3 Trustpilot rating across 190+ reviews and an A- BBB rating, Lemonaid demonstrates solid patient satisfaction and institutional trust. The review volume is on the lower side, but the quality metrics are encouraging.
The clinical program is straightforward — medium provider quality and ongoing support, with no lab testing or dietitian access included. This is by design: Lemonaid prioritizes efficient access over comprehensive care, making it best suited for patients who want a reliable prescription service rather than a full obesity management program.
At a Glance
Medications Offered
Ozempic, Wegovy, Compounded Semaglutide
Both
Cost & Insurance
- Monthly: $49/mo + $299 meds
- 6-month estimate: $2,088
- Insurance: No / positioned as skip-the-insurance-hassle self-pay
- Self-pay: Yes
Clinical Features
- Lab testing: No
- Dietitian access: No
- Verified Pharmacy: Partner pharmacies not publicly disclosed (23andMe subsidiary)
- BBB Rating: A-
Delivery & Access
- Format: Both
- Nationwide telehealth: Yes
- Speed: Fast
- Spanish-speaking providers: Not available
Start your GLP-1 weight loss journey with Lemonaid Health today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.
What the Lemonaid Health Intake Looks Like
We walked through Lemonaid Health’s GLP-1 weight-loss intake ourselves, from the opening goal question to account creation. Lemonaid runs its clinical review entirely in async provider chat after checkout — so the public intake is the leanest in our catalog.
Very low. The public intake does not capture height, weight, BMI, pancreatitis history, MTC/MEN2, pregnancy, current medications, allergies, mental health, or any structured comorbidity. All of that is deferred to an async provider chat after checkout.
Low. Eleven short screens, around two minutes to reach account creation, no video call required in most states, and the reassurance “No charges until you’re approved” removes the financial hesitation for curious shoppers.
The 6 Stages
What the Public Intake Doesn’t Ask
Lemonaid’s model is e-commerce-style: the web intake is a product selection form, and the clinical assessment is an asynchronous messaging conversation with a provider that happens after account creation. The final screen tells patients “A provider will soon be reaching out to you through your secure chat to confirm your prescription” and notes that in most states a video call is not required. This is the fastest path to a live conversation with a GLP-1 provider in our catalog — but it also means that any shopper who treats the web intake as the full clinical screen will walk away with the wrong mental model. The real safety screening happens in the chat, not on the public forms.
Unusual for GLP-1 intake flows: Lemonaid asks the patient to pick a specific product from a price list before any clinical review. The menu ranges from microdose compounded options at $129/month up to brand Wegovy at $1,599/month, with compounded semaglutide and tirzepatide options in between. That design choice is friendly for experienced GLP-1 users who already know what they want, but it places the burden of matching a drug to a BMI, a budget, and a safety profile on the patient rather than the provider. The provider can change the prescription during async review, but the default is patient-selected.
Source: GLP-1.Reviews editorial walkthrough on April 13, 2026. We completed every screen of the Lemonaid Health weight-loss intake using a representative GLP-1 candidate persona and stopped before submitting any payment information.
Opens lemonaidhealth.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.
